US Edition
LifeArc joins the REMEDi4ALL Consortium, a pioneering global platform shaping the future of drug repurposing
Summary by LifeArc
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
LifeArc joins the REMEDi4ALL Consortium, a pioneering global platform shaping the future of drug repurposing
LifeArc and the EU-funded project, REMEDi4ALL, have announced a collaboration agreement to strengthen the partnership’s potential to transform and accelerate the repurposing of medicines in Europe. Focusing on drug repositioning The agreement reflects the increased interest in drug repositioning and repurposing as a faster, more cost-effective strategy to complement de novo drug development approaches. Such medicines repurposing holds particular…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
